Page last updated: 2024-09-05

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and Disease Models, Animal

2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose has been researched along with Disease Models, Animal in 1 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buffone, A; Chandrasekaran, EV; Lau, JT; Locke, RD; Marathe, DD; Matta, KL; Nasirikenari, M; Neelamegham, S; Xue, J1

Other Studies

1 other study(ies) available for 2-acetamido-1,3,6-tri-o-acetyl-4-deoxy-4-fluoroglucopyranose and Disease Models, Animal

ArticleYear
Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.
    Blood, 2010, Feb-11, Volume: 115, Issue:6

    Topics: Acetylation; Acetylglucosamine; Animals; Blotting, Western; Bone Marrow Cells; Cell Adhesion; Cell Movement; Chemotaxis, Leukocyte; Disease Models, Animal; Flow Cytometry; Glycosylation; HL-60 Cells; Humans; Leukocytes; Lewis Blood Group Antigens; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Peritonitis; Polysaccharides; Protein Binding

2010